Arquer Diagnostics

Arquer Diagnostics is a UK-based, female-led company specializing in the development and commercialization of non-invasive, highly accurate, and cost-effective cancer biomarker tests. The company operates in the oncology diagnostics market, focusing on transforming how patients are diagnosed with cancer and monitored throughout their treatment journey. Arquer Diagnostics serves healthcare providers, particularly urologists, who can order their flagship product, ADXBLADDER, through distribution partners. The business model revolves around the sale of these diagnostic tests, which are designed to detect cancer biomarkers in bodily fluids such as urine. Revenue is generated through direct sales to healthcare providers and partnerships with distribution channels. The company is supported by internationally recognized clinical advisors who guide their research programs, clinical studies, and dissemination of clinical information.

Keywords: cancer diagnostics, biomarker tests, non-invasive, oncology, bladder cancer, urologists, healthcare providers, UK-based, female-led, ADXBLADDER.